M. Tateishi et al., Long-term results of corticosteroid administration via appendicostomy in patients with ulcerative colitis involving the entire colon, INT SURG, 83(3), 1998, pp. 235-240
Background: Ulcerative colitis (UC) of an unknown etiology frequently demon
strates repeated active and inactive stages, As a result, it is difficult t
o sustain long-term remission under conservative therapy,
Methods: Ten patients who presented suffering from UC involving the entire
colon were treated. All patients had been previously treated at other hospi
tals usually with sulphasalazine and either corticosteroids or steroid enem
as for the primary complaints of muco-bloody stool or frequent diarrhea, Al
l patients underwent either an appendicostomy or cecostomy, and were inject
ed with dexamethasone via an artificial fistula twice a day,
Results: This treatment led to remission, and, as a result, the symptoms of
anal bleeding or muco-bloody stools disappeared in all patients, Radiologi
cal, endoscopic, and pathological studies revealed a dramatic response to s
teroid injection from the fistula, The mean follow-up period was 44.7 month
s (3-122 months), Eight patients remained free from any symptoms of UC, One
underwent a proctocolectomy because of side effects due to steroid treatme
nt, The other patient died suddenly of unknown causes, The mean symptom-fre
e period after cecal injection was 39.5 months (1-119 months), The mean pro
portion of disease free period from UC, compared with the total follow-up p
eriod after surgery, was 88%, After remission, eight patients were able to
return to a normal lifestyle at home using a peritoneal button. They could
also take a bath and continue their school or social lives in almost the sa
me way as healthy persons,
Conclusions: We thus recommend this new minimally-invasive therapy for pati
ents with UC involving the entire colon who demonstrate resistance to conve
ntional conservative therapy As a result of such treatment, all patients we
re able to achieve a comfortable lifestyle after undergoing minimally-invas
ive surgery.